Location of Lesions Responsible for Blood Loss in the Gastrointestinal (GI) Tract (NCT04840433) | Clinical Trial Compass
UnknownNot Applicable
Location of Lesions Responsible for Blood Loss in the Gastrointestinal (GI) Tract
Hong Kong180 participantsStarted 2021-04-12
Plain-language summary
The purpose of this study is to identify the prevalence, nature and location of lesions in the GI tract that may contribute to iron deficiency anaemia and compare diagnostic yied of the upper GI magnetic controlled capsule endoscopy with conventional gastroscopy.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female patients aged 18 years and over and up to but not exceeding 80 years
* Patients presenting with IDA whom require gastroscopy and colonoscopy as per national guidelines (1)
Exclusion Criteria:
* Patients who have contraindications to gastroscopy or colonoscopy
* Patients under the age of 18 years
* Patients over the age of 80 years
* Active vomiting
* Patients with a permanent pacemaker, implantable cardioverter-defibrillator or REVEAL device
* Patients with any electronic/magnetic/mechanically controlled devices e.g. sacral nerve stimulators, bladder stimulators
* Patients with dysphagia, odynophagia or known swallowing disorder
* Patients with known Zenker's diverticulum
* Patients with suspected bowel obstruction or bowel perforation
* Patients with prior bowel obstruction
* Patients with gastroparesis or known gastric outlet obstruction
* Patients with known Crohn's disease
* Patients who are taking daily non-steroidal anti-inflammatory drugs (excluding prophylactic doses of aspirin) for more than six months
* Patients who have received abdominopelvic radiotherapy treatment
* Patients with a history of GI tract surgery (Billroth I, Billroth II, Oesophagectomy, gastrectomy or bariatric procedure)
* Patients that are pregnant or lactating
* Patients with altered mental status that would limit their ability to swallow
* Patients with allergy to conscious sedation, polyethylene glycol or metoclopramide
* Patients unwilling to swallow th…
What they're measuring
1
Prevalence and nature of lesions in the upper GI tract, small bowel and colon that cause IDA